French start-up baCta uses genetically engineered E.coli bacteria to create natural rubber in a lab using glucose as its feedstock. The company recently recieved €3.3m ($3.6m) in funding to help it find ways to industrialise its process and tackle the challenge of producing raw material on the scale required by other manufacturers.
More than 50% of the world's rubber is synthetic and produced from petroleum. Natural rubber is harvested from Hevea trees' latex. The ways of producing both types are not great from a sustainability perspective.
If a renewable raw material like biosynthesised natural rubber can be created, there would be a clear incentive for manufacturers to switch to a more sustainable option and reduce carbon footprint.
BaCta's CEO Mathieu Nohet is adamant that its biosynthesised natural rubber can compete with non-sustainable options if scale is achieved. He believes the company's polymerisation mechanism inside the E.coli cells creates more significant yields and cost efficiency when using different feedstocks.
Nohet has stated that his start-up hopes to target luxury fashion and apparel brands initially and then expand to industry once it has figured out scaling.
BaCta hopes to reach pilot scale in 18 months and receive pre-industrial scale funding in addition to the funding recently secured from OVNI Capital, another.vc, Kima Ventures and Sharpstone Capital.
As genetically engineered natural rubber production removes specific proteins that trigger allergies, the start-up views biosynthesised natural rubber as potentially hypoallergenic.
BaCta also has plans for producing carbon neutral isoprenoids for use in industrial and pharmaceutical production.
Rubber is an understandable, familiar product that can be approached an initial step towards wider missions.